Press Releases

Read Regulatory and non-regulatory press releases

  • All
  • Non-Regulatory
  • Regulatory
Regulatory

MPI is issued patent in Australia

Regulatory

CORRECTION: MPI is issued patent in Australia

Regulatory

MPI – NOTICE OF EXTRAORDINARY GENERAL MEETING

Regulatory

MPI – INDKALDELSE TIL EKSTRAORDINÆR GENERALFORSAMLING

Non-Regulatory

MPI : Fly Fishing, Photography & Solving Cancer…Same Same but Different!

Non-Regulatory

MPI participates at Biotech Showcase in San Francisco

Regulatory

MPI and Mundipharma EDO GmbH enters agreement of DRP(TM) for their anti cancer lead compound EDO-S101 in clinical trials

Regulatory

MPI og Mundipharma EDO GmbH indgår aftale om brug af MPI’s DRP(TM) biomarkør til deres førende lægemiddelkandidat EDO-S101 til behandling af kræft i kliniske forsøg

Regulatory

MPI unblinds prospective study of LungChip prognosticator in early lung cancer

Regulatory

MPI afblinder prospektivt studie af LungChip prognosticator i tidlig lungekræft

Regulatory

DRP(TM) enables Irofulven clinical trial in prostate cancer

Non-Regulatory

New academic drug screening platform for cancer treatment

Regulatory

Presentation of use of DRP(TM) in Top1 at AACR congress in Boston

Non-Regulatory

MPI – announces 3 abstracts on the AACR/NCI/EORTC International Conference on Molecular Targets and Cancer Therapeutics in Boston

Regulatory

Medical Prognosis Institute A/S – Interim Report First Half 2015

Regulatory

MPI will publish its half-year report for the first half year of 2015 on August 31st

Non-Regulatory

MPI’s spinout, Oncology Venture announces first day of trading at the Swedish stock exchange AktieTorget

Regulatory

MPI’s spinout, Oncology Venture announces oversubscription of 370 % of its emission prior to listing at the AktieTorget

Regulatory

MPI’s spin-out, Oncology Venture annoncerer overtegning på 370% i forbindelse med aktieemission før IPO på AktieTorget

Regulatory

Oncology Venture Sweden AB, a spinout from MPI announces its IPO at the Swedish AktieTorget